Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Am J Trop Med Hyg ; 97(1): 84-87, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28719293

ABSTRACT

We herein report a case of suspected Borrelia miyamotoi disease in Hokkaido, Japan. The patient complained of lassitude, arthralgia, and high fever after a tick bite. Furthermore, at the time of consultation, the patient exhibited momentary loss of consciousness and low blood pressure. Laboratory tests revealed elevation of liver enzymes, thrombocytopenia, and increased C-reactive protein. Seroconversion to B. miyamotoi glycerophosphoryl diester phosphodiesterase antigen suggested the patient was infected with a relapsing fever group Borrelia species.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Borrelia/isolation & purification , Relapsing Fever/diagnosis , Relapsing Fever/drug therapy , Tick-Borne Diseases/diagnosis , Tick-Borne Diseases/drug therapy , Adult , Animals , Humans , Japan , Male , Treatment Outcome
2.
Gan To Kagaku Ryoho ; 36(8): 1321-5, 2009 Aug.
Article in Japanese | MEDLINE | ID: mdl-19692771

ABSTRACT

In performing FOLFOX chemotherapy (infusional 5-FU/LV with oxaliplatin) for advanced colorectal cancer, the neurotoxicity of oxaliplatin (L-OHP) is the dose-limiting factor. A retrospective study of 25 consecutive patients, receiving modified FOLFOX6 (mFOLFOX6) for advanced colorectal cancer, was conducted. From March 2006 to February 2008, we investigated the process of development of sensory neuropathy by adverse effect grading and our original interview-based intake about the afflicted regions. Neurotoxicity developed in 21 cases (84%) after 6 courses and the cumulative L-OHP dose was 410 mg/m(2) in median. In 11 cases (52%), it developed from the fingers, while in 8 cases (38%), it occurred from the fingers and toes simultaneously. It developed from the toes or tongue only in one case each. In 6 cases (55%), in which it occurred from the fingers, the symptom aggravated to grade 2 (G2) according to the Neurotoxicity Criteria of DEBIOPHARM (DEBNTC). On the other hand, in cases of coexpression of the fingers and toes, 7 cases (88%) developed G2 neuropathy, among one of whom suffered from grade 3 (G3). The coexistence of diabetes mellitus without neuropathy had no influence on the development of the neurotoxicity in the grading of DEB-NTC. One month after the last mFOLFOX6 therapy, neurotoxicity newly developed in one case, and was aggravated in two cases two months after cessation of the chemotherapy. Therefore, careful observation of the course should be continued even after the end of mFOLFOX6 therapy. Our results suggest that L-OHP neurotoxicity develops on fingers or fingers and toes simultaneously in most cases. And when it occurred on fingers and toes simultaneously, it would aggravate to G2 or G3 during the chemotherapy. The interviewed-based intake about the afflicted region, such as ours, can be used to predict the deterioration of the neurotoxicity.


Subject(s)
Antineoplastic Agents/adverse effects , Colorectal Neoplasms/drug therapy , Organoplatinum Compounds/adverse effects , Sensation Disorders/chemically induced , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/toxicity , Female , Humans , Interviews as Topic , Male , Middle Aged , Organoplatinum Compounds/toxicity , Oxaliplatin , Retrospective Studies , Sensation Disorders/physiopathology , Sensory Receptor Cells/drug effects
3.
Breast Cancer ; 10(4): 378-81, 2003.
Article in English | MEDLINE | ID: mdl-14634520

ABSTRACT

A 46-year-old woman presented to our hospital with a rapidly growing lump in her right breast. Fine-needle aspiration (FNA) cytology and core needle biopsy of the mass revealed many epithelioid cells admixed with multinucleated Langhans-type giant cells, neutrophils, lymphocytes, and stromal cells, leading to a diagnosis of granulomatous mastitis. Mammography and ultrasonography provided little information for differentiating between granulomatous mastitis and carcinoma. This patient was successfully treated with low dose and short period of corticosteroid therapy.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Biopsy, Needle , Granuloma/diagnosis , Granuloma/drug therapy , Mastitis/diagnosis , Mastitis/drug therapy , Prednisolone/therapeutic use , Biopsy, Needle/methods , Female , Humans , Middle Aged , Treatment Outcome , Ultrasonography, Mammary
SELECTION OF CITATIONS
SEARCH DETAIL
...